NKTR- Nektar Therapeutics

Name: Nektar Therapeutics Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Nektar Therapeutics (NKTR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. NKTR is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Robin Howard W	75.9K	$4.99M	-
Other	Wilson Mark Andrew	21.6K	$1.42M	-
Other	Zalevsky Jonathan	15.4K	$1.01M	-5,538
Dir	Ajer Jeffrey Robert	8.0K	$525.6K	-
Dir	Greer R Scott	8.0K	$525.6K	-

Activity

Buys and sells only

Transactions

10 filings · page 10

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 16, 2021	Robin Howard W58	President &CEO	Sell	11,515	$13.83	$159,252.45	-2.6%	-3.1%	-66.0%
Aug 16, 2021	Thomsen Jillian B.86	SVP &Chief Accounting Officer	Sell	13,339	$13.83	$184,478.37	-8.8%	-3.1%	-66.0%
Aug 16, 2021	Northcott John79	SVP &Chief Commercial Officer	Sell	6,192	$13.83	$85,635.36	-3.0%	-3.1%	-66.0%
Jul 22, 2021	Chess Robert84	Director	Sale+OE	5,721	$16.81	$96,148.04	-0.7%	-0.9%	-77.5%
May 17, 2021	Zalevsky Jonathan63	Chief R&D Officer	Sell	31,111	$18.30	$569,331.30	-11.7%	-24.3%	-78.3%
May 17, 2021	Wilson Mark Andrew58	SVP &General Counsel	Sell	1,917	$18.30	$35,081.10	-2.5%	-24.3%	-78.3%
May 17, 2021	Thomsen Jillian B.86	SVP &Chief Accounting Officer	Sell	13,391	$18.30	$245,055.30	-8.1%	-24.3%	-78.3%
May 17, 2021	Robin Howard W58	President &CEO	Sell	11,560	$18.30	$211,548.00	-2.6%	-24.3%	-78.3%
May 17, 2021	Northcott John79	SVP &Chief Commercial Officer	Sell	6,085	$18.30	$111,355.50	-2.9%	-24.3%	-78.3%
May 17, 2021	Labrucherie Gil M84	SVP, COO &CFO	Sell	7,898	$18.30	$144,533.40	-3.0%	-24.3%	-78.3%

← PrevPage 10Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC